Considerations When Initiating Neratinib for Breast Cancer: How to Prevent and Treat Diarrhea

Oncology (Williston Park). 2019 Jun 19;33(6):232-4.
No abstract available

MeSH terms

  • Antidiarrheals / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Clinical Trials as Topic
  • Diarrhea / chemically induced*
  • Diarrhea / prevention & control
  • Diarrhea / therapy*
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / metabolism
  • Female
  • Humans
  • Premedication
  • Prognosis
  • Quinolines / administration & dosage
  • Quinolines / adverse effects*

Substances

  • Antidiarrheals
  • Quinolines
  • EGFR protein, human
  • ErbB Receptors
  • neratinib